“Co-op” Lets Users Barter DNA and Health Information for Shares
Shawna Williams | Dec 7, 2018
LunaDNA receives Securities and Exchange Commission approval to treat the data as currency.
Former Taiwanese National Academy Head Cleared of Corruption
Former Taiwanese National Academy Head Cleared of Corruption
Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.
Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.
First Blockchain-based Genomic Data Marketplace Launches
Shawna Williams | Nov 5, 2018
EncrypGen will enable individuals to sell their deidentified data for research.
Call to Stop Using the Term “Mesenchymal Stem Cell”
Abby Olena | Sep 26, 2018
Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.
Opinion: A Modest Proposal to Address NIH Insanity
Henry J. Rozycki | Aug 22, 2018
Silicon Valley’s early-stage funding model could address a dearth of opportunities for young investigators just launching new projects.
Researchers React to Microsoft’s Acquisition of GitHub
Anna Azvolinsky | Jun 7, 2018
Computational biologists are optimistic that the purchase of the world’s largest hub for open-source computer code will not affect the way they use GitHub for science.
MyHeritage Account Data Compromised in “Cybersecurity Incident”
Catherine Offord | Jun 6, 2018
A security researcher found the email addresses and encrypted passwords of more than 92 million users of the genealogy site on a private server outside the company.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
SEC Charges Theranos With Fraud
Jim Daley | Mar 14, 2018
The company raised more than $700 million based on false claims to investors, according to the complaint.